The probiotic Lactobacillus GG may augment intestinal host defense by regulating apoptosis and promoting

Patricia W Lin1, Tala R Nasr, Andrew J Berardinelli

  • 1Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia 30322, USA. Patricia_Lin@oz.ped.emory.edu

Pediatric Research
|June 17, 2008
PubMed

Insights

Probiotics like Lactobacillus rhamnosus GG (LGG) reduce intestinal epithelial apoptosis in preterm infants. LGG stimulates antiapoptotic and cytoprotective genes, potentially preventing necrotizing enterocolitis (NEC).

Area of Science:

  • Gastroenterology
  • Neonatology
  • Microbiology

Background:

  • Necrotizing enterocolitis (NEC) is a major cause of illness and death in preterm infants.
  • Inappropriate apoptosis of mucosal epithelia is a suspected factor in NEC development.
  • Probiotics show promise in reducing NEC incidence and suppressing intestinal cell apoptosis.

Purpose of the Study:

  • To investigate the in vivo mechanism of probiotic Lactobacillus rhamnosus GG (LGG) in modulating intestinal epithelial apoptosis.
  • To confirm LGG's antiapoptotic effects in the developing intestine.
  • To identify molecular pathways influenced by LGG in vivo.

Main Methods:

  • In vitro confirmation of LGG's ability to reduce chemically induced intestinal epithelial apoptosis.
  • Oral administration of LGG to live animals, followed by ex vivo apoptosis measurement (caspase 3, TUNEL staining).
  • cDNA microarray analysis of intestinal tissue from LGG-treated mice to assess gene expression.

Main Results:

  • LGG effectively reduced chemically induced intestinal epithelial apoptosis in vitro.
  • Oral LGG administration in vivo decreased chemically induced apoptosis ex vivo.
  • LGG up-regulated multiple cytoprotective and antiapoptotic genes in the mouse intestine.

Conclusions:

  • Probiotics like LGG can enhance intestinal defenses in the developing gut by promoting antiapoptotic and cytoprotective responses.
  • Understanding how probiotics affect apoptotic pathways is crucial for developing targeted NEC therapies.
  • LGG demonstrates potential as a preventive strategy against NEC by modulating epithelial cell apoptosis.

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...